Catalyst Pharmaceuticals, Inc. - Common Stock - Bilanço (NASDAQ:CPRX) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 192.35 M237.79 M375.63 M470.11 M851.41 M1.1 B Toplam yükümlülükler 22.76 M30.96 M75.21 M82.23 M123.78 M149.71 M Toplam özsermaye 169.6 M206.83 M300.42 M387.88 M727.63 M954.27 M Toplam yükümlülükler ve hissedarların özsermayesi 192.35 M237.79 M375.63 M470.11 M851.41 M1.1 B Toplam borç —————— Net borç ——————

Haberler

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

CPRX or UTHR: Which Is the Better Value Stock Right Now?

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y

Catalyst Pharmaceuticals kazancı $0,06 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y